Free Trial

Smith & Nephew plc (LON:SN) Insider Deepak Nath Sells 34,033 Shares

Smith & Nephew logo with Medical background
Remove Ads

Smith & Nephew plc (LON:SN - Get Free Report) insider Deepak Nath sold 34,033 shares of Smith & Nephew stock in a transaction that occurred on Thursday, December 5th. The shares were sold at an average price of GBX 981 ($12.52), for a total transaction of £333,863.73 ($426,009.61).

Smith & Nephew Stock Down 0.6 %

Smith & Nephew stock traded down GBX 5.60 ($0.07) during mid-day trading on Friday, reaching GBX 978.80 ($12.49). The company had a trading volume of 1,910,354 shares, compared to its average volume of 343,671. The company has a current ratio of 2.51, a quick ratio of 0.84 and a debt-to-equity ratio of 70.22. The stock has a market cap of £8.53 billion, a price-to-earnings ratio of 3,625.19, a price-to-earnings-growth ratio of 0.46 and a beta of 0.62. The stock's 50 day simple moving average is GBX 1,042.88 and its 200 day simple moving average is GBX 1,075.48.

Smith & Nephew Company Profile

(Get Free Report)

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.

Featured Stories

Should You Invest $1,000 in Smith & Nephew Right Now?

Before you consider Smith & Nephew, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Smith & Nephew wasn't on the list.

While Smith & Nephew currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads